表紙:アレルギー治療薬市場- 治療別、タイプ別、投与経路別、流通チャネル別、世界予測、2023年~2032年
市場調査レポート
商品コード
1370622

アレルギー治療薬市場- 治療別、タイプ別、投与経路別、流通チャネル別、世界予測、2023年~2032年

Allergy Therapeutics Market - By Treatment (Anti-allergy drug, Immunotherapy ), Type (Rhinitis, Asthma, Skin, Food, Eye), Route of Administration, Distribution Channel, Global Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 215 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アレルギー治療薬市場- 治療別、タイプ別、投与経路別、流通チャネル別、世界予測、2023年~2032年
出版日: 2023年08月25日
発行: Global Market Insights Inc.
ページ情報: 英文 215 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー治療薬市場は、2023年から2032年にかけて6.6%のCAGRを示します。

花粉症や食物アレルギーのような呼吸器系アレルギーを含むアレルギーの有病率の増加が、効果的な治療法の需要を促進しています。アレルギー診断や免疫療法技術の進歩により治療成績が向上し、事業の成長を後押ししています。

アレルギーとその健康への影響に対する意識の高まりは、医療介入を求める個人を促し、市場拡大の好材料となります。さらに、公害や気候パターンの変化などの環境要因がアレルギーの発症率上昇につながり、事業成長の新たな可能性をもたらしています。

さらに、医療政策の支援、共同イニシアティブ、新規アレルギー治療薬の開発は、市場の進展をさらに後押しします。サノフィSAは2023年7月、健康・ウェルネス業界に特化した米国の著名ブランドであるQunolの買収に合意したと発表しました。

市場は、治療タイプ、種類、投与経路、流通チャネル、地域に基づいて分別されます。

治療タイプ別では、免疫療法がアレルギーの根本原因に対処し、症状の重篤度を軽減し、患者に長期的な緩和をもたらすという有効性が認知されつつあることが、この治療法の事業成長を牽引しています。

タイプ別では、喘息分野は2023~2032年にCAGR 7.2%を記録すると予測されます。これは、喘息の有病率の増加、喘息治療薬の研究拡大、喘息患者に対するより高度で的を絞った治療法の開発などの要因が、同分野の成長を後押ししているためです。

経鼻投与経路セグメントは、分析期間を通じてCAGR 6.8%を示すと思われます。非侵襲的治療に対する利便性と患者の嗜好、アレルギー症状の管理における経鼻投与の有効性、経鼻アレルギー治療における継続的な技術革新が、このセグメントの成長を促進するであろう。

地域別では、アジア太平洋地域のアレルギー治療薬産業は、アレルギー有病率の増加とヘルスケアインフラの台頭により、分析期間中にCAGR 7%で成長すると推定されます。さらに、患者の意識の拡大と効果的なアレルギー治療に対する需要の高まりが、同地域の事業成長を促進します。

目次

第1章 調査手法とスコープ

  • 市場範囲と定義
  • 基本推定と計算
  • 予測パラメータ
  • COVID-19影響分析
  • データ検証
  • データソース
    • 一次データ
    • 2次データ
      • 有料情報源
      • 無報酬情報源

第2章 エグゼクティブサマリー

第3章 アレルギー治療薬の産業洞察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • アレルギー疾患の有病率の増加
      • アレルギーとその健康への影響に対する意識の高まり
      • バイオテクノロジー、ゲノミクス、個別化医療における進歩の高まり
      • 新しく改良された治療オプションに対する需要の増加
      • ヘルスケア支出の増加
    • 業界の潜在的リスク&課題
      • 副作用と安全性への懸念
      • アレルゲン抽出物の標準化の欠如
      • 認識不足、軽い症状、ヘルスケアへのアクセス制限による未診断または過小診断例
  • 成長の可能性分析
  • COVID-19インパクト分析
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 企業シェア分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニング・マトリックス
  • 戦略展望マトリックス

第5章 アレルギー治療薬の市場規模・予測:治療タイプ別

  • 主要動向:治療タイプ別
  • 抗アレルギー薬
    • 抗ヒスタミン薬
    • 副腎皮質ステロイド薬
    • うっ血除去薬
    • その他の薬剤
  • 免疫療法
    • 皮下免疫療法(SCIT)
    • 舌下免疫療法(SLIT)

第6章 アレルギー治療薬の市場規模・予測:タイプ別

  • 主要動向:タイプ別
  • 眼アレルギー
  • 喘息
  • 皮膚アレルギー
  • 食物アレルギー
  • 鼻炎
  • その他のアレルギー

第7章 アレルギー治療薬の市場規模・予測:投与経路別

  • 主要動向:投与経路別
  • 経口剤
  • 吸入薬
  • 経鼻剤
  • その他の投与経路

第8章 アレルギー治療薬の市場規模・予測:流通チャネル別

  • 主要動向:流通チャネル別
  • 病院薬局
  • 小売薬局
  • その他の流通チャネル

第9章 アレルギー治療薬の市場規模・予測:地域別

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第10章 企業プロファイル

  • Allergopharma
  • Danaher
  • AbbVie, Inc.
  • Allergy Therapeutics plc
  • Sanofi SA
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
図表

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by treatment type (2022)
  • TABLE 3. Market revenue, by type (2022)
  • TABLE 4. Market revenue, by route of administration (2022)
  • TABLE 5. Market share, by distribution channel (2022)
  • TABLE 6. Market share, by region (2022)
  • TABLE 7. Global allergy therapeutics market size, 2018-2022, (USD Million)
  • TABLE 8. Global allergy therapeutics market size, 2023-2032, (USD Million)
  • TABLE 9. Global allergy therapeutics market size, by region, 2018-2022 (USD Million)
  • TABLE 10. Global allergy therapeutics market size, by region, 2023-2032 (USD Million)
  • TABLE 11. Global allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 12. Global allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 13. Global allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 14. Global allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 15. Global allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 16. Global allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 17. Global allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 18. Global allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 19. Industry impact forces
  • TABLE 20. Anti-allergy drugs market size, 2018-2022 (USD Million)
  • TABLE 21. Anti-allergy drugs market size, 2023-2032 (USD Million)
  • TABLE 22. Antihistamines market size, 2018-2022 (USD Million)
  • TABLE 23. Antihistamines market size, 2023-2032 (USD Million)
  • TABLE 24. Corticosteroids market size, 2018-2022 (USD Million)
  • TABLE 25. Corticosteroids market size, 2023-2032 (USD Million)
  • TABLE 26. Decongestants market size, 2018-2022 (USD Million)
  • TABLE 27. Decongestants market size, 2023-2032 (USD Million)
  • TABLE 28. Other drugs market size, 2018-2022 (USD Million)
  • TABLE 29. Other drugs market size, 2023-2032 (USD Million)
  • TABLE 30. immunotherapy market size, 2018-2022 (USD Million)
  • TABLE 31. immunotherapy market size, 2023-2032 (USD Million)
  • TABLE 32. Sub-cutaneous immunotherapy (SCIT) market size, 2018-2022 (USD Million)
  • TABLE 33. Sub-cutaneous immunotherapy (SCIT) market size, 2023-2032 (USD Million)
  • TABLE 34. Sub-lingual immunotherapy (SLIT) market size, 2018-2022 (USD Million)
  • TABLE 35. Sub-lingual immunotherapy (SLIT) market size, 2023-2032 (USD Million)
  • TABLE 36. Eye allergy market size, 2018-2022 (USD Million)
  • TABLE 37. Eye allergy market size, 2023-2032 (USD Million)
  • TABLE 38. Asthma market size, 2018-2022 (USD Million)
  • TABLE 39. Asthma market size, 2023-2032 (USD Million)
  • TABLE 40. Skin allergy market size, 2018-2022 (USD Million)
  • TABLE 41. Skin allergy market size, 2023-2032 (USD Million)
  • TABLE 42. Food allergies market size, 2018-2022 (USD Million)
  • TABLE 43. Food allergies market size, 2023-2032 (USD Million)
  • TABLE 44. Rhinitis market size, 2018-2022 (USD Million)
  • TABLE 45. Rhinitis market size, 2023-2032 (USD Million)
  • TABLE 46. Other allergy types market size, 2018-2022 (USD Million)
  • TABLE 47. Other allergy types market size, 2023-2032 (USD Million)
  • TABLE 48. Oral market size, 2018-2022 (USD Million)
  • TABLE 49. Oral market size, 2023-2032 (USD Million)
  • TABLE 50. Inhalers market size, 2018-2022 (USD Million)
  • TABLE 51. Inhalers market size, 2023-2032 (USD Million)
  • TABLE 52. Intranasal market size, 2018-2022 (USD Million)
  • TABLE 53. Intranasal market size, 2023-2032 (USD Million)
  • TABLE 54. Other routes of administration market size, 2018-2022 (USD Million)
  • TABLE 55. Other routes of administration market size, 2023-2032 (USD Million)
  • TABLE 56. Hospital pharmacies market size, 2018-2022 (USD Million)
  • TABLE 57. Hospital pharmacies market size, 2023-2032 (USD Million)
  • TABLE 58. Retail pharmacies market size, 2018-2022 (USD Million)
  • TABLE 59. Retail pharmacies market size, 2023-2032 (USD Million)
  • TABLE 60. Other distribution channels market size, 2018-2022 (USD Million)
  • TABLE 61. Other distribution channels market size, 2023-2032 (USD Million)
  • TABLE 62. North America allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 63. North America allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 64. North America allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 65. North America allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 66. North America allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 67. North America allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 68. North America allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 69. North America allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 70. North America allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 71. North America allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 72. North America allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 73. North America allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 74. North America allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 75. North America allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 76. U.S. allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 77. U.S. allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 78. U.S. allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 79. U.S. allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 80. U.S. allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 81. U.S. allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 82. U.S. allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 83. U.S. allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 84. U.S. allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 85. U.S. allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 86. U.S. allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 87. U.S. allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 88. Canada allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 89. Canada allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 90. Canada allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 91. Canada allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 92. Canada allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 93. Canada allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 94. Canada allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 95. Canada allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 96. Canada allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 97. Canada allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 98. Canada allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 99. Canada allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 100. Europe allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 101. Europe allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 102. Europe allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 103. Europe allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 104. Europe allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 105. Europe allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 106. Europe allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 107. Europe allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 108. Europe allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 109. Europe allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 110. Europe allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 111. Europe allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 112. Europe allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 113. Europe allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 114. Germany allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 115. Germany allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 116. Germany allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 117. Germany allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 118. Germany allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 119. Germany allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 120. Germany allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 121. Germany allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 122. Germany allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 123. Germany allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 124. Germany allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 125. Germany allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 126. UK allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 127. UK allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 128. UK allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 129. UK allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 130. UK allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 131. UK allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 132. UK allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 133. UK allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 134. UK allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 135. UK allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 136. UK allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 137. UK allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 138. France allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 139. France allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 140. France allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 141. France allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 142. France allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 143. France allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 144. France allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 145. France allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 146. France allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 147. France allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 148. France allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 149. France allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 150. Italy allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 151. Italy allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 152. Italy allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 153. Italy allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 154. Italy allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 155. Italy allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 156. Italy allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 157. Italy allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 158. Italy allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 159. Italy allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 160. Italy allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 161. Italy allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 162. Spain allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 163. Spain allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 164. Spain allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 165. Spain allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 166. Spain allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 167. Spain allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 168. Spain allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 169. Spain allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 170. Spain allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 171. Spain allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 172. Spain allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 173. Spain allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 174. Rest of Europe allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 175. Rest of Europe allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 176. Rest of Europe allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 177. Rest of Europe allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 178. Rest of Europe allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 179. Rest of Europe allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 180. Rest of Europe allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 181. Rest of Europe allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 182. Rest of Europe allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 183. Rest of Europe allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 184. Rest of Europe allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 185. Rest of Europe allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 186. Asia Pacific allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 187. Asia Pacific allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 188. Asia Pacific allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 189. Asia Pacific allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 190. Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 191. Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 192. Asia Pacific allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 193. Asia Pacific allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 194. Asia Pacific allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 195. Asia Pacific allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 196. Asia Pacific allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 197. Asia Pacific allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 198. Asia Pacific allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 199. Asia Pacific allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 200. Japan allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 201. Japan allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 202. Japan allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 203. Japan allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 204. Japan allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 205. Japan allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 206. Japan allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 207. Japan allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 208. Japan allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 209. Japan allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 210. Japan allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 211. Japan allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 212. China allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 213. China allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 214. China allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 215. China allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 216. China allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 217. China allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 218. China allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 219. China allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 220. China allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 221. China allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 222. China allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 223. China allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 224. India allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 225. India allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 226. India allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 227. India allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 228. India allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 229. India allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 230. India allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 231. India allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 232. India allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 233. India allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 234. India allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 235. India allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 236. Australia allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 237. Australia allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 238. Australia allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 239. Australia allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 240. Australia allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 241. Australia allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 242. Australia allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 243. Australia allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 244. Australia allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 245. Australia allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 246. Australia allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 247. Australia allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 248. Rest of Asia Pacific allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 249. Rest of Asia Pacific allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 250. Rest of Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 251. Rest of Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 252. Rest of Asia Pacific allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 253. Rest of Asia Pacific allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 254. Rest of Asia Pacific allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 255. Rest of Asia Pacific allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 256. Rest of Asia Pacific allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 257. Rest of Asia Pacific allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 258. Rest of Asia Pacific allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 259. Rest of Asia Pacific allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 260. Latin America allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 261. Latin America allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 262. Latin America allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 263. Latin America allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 264. Latin America allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 265. Latin America allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 266. Latin America allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 267. Latin America allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 268. Latin America allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 269. Latin America allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 270. Latin America allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 271. Latin America allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 272. Latin America allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 273. Latin America allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 274. Brazil allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 275. Brazil allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 276. Brazil allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 277. Brazil allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 278. Brazil allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 279. Brazil allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 280. Brazil allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 281. Brazil allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 282. Brazil allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 283. Brazil allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 284. Brazil allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 285. Brazil allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 286. Mexico allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 287. Mexico allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 288. Mexico allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 289. Mexico allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 290. Mexico allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 291. Mexico allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 292. Mexico allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 293. Mexico allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 294. Mexico allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 295. Mexico allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 296. Mexico allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 297. Mexico allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 298. Rest of Latin America allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 299. Rest of Latin America allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 300. Rest of Latin America allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 301. Rest of Latin America allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 302. Rest of Latin America allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 303. Rest of Latin America allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 304. Rest of Latin America allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 305. Rest of Latin America allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 306. Rest of Latin America allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 307. Rest of Latin America allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 308. Rest of Latin America allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 309. Rest of Latin America allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 310. Middle East & Africa allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 311. Middle East & Africa allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 312. Middle East & Africa allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 313. Middle East & Africa allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 314. Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 315. Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 316. Middle East & Africa allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 317. Middle East & Africa allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 318. Middle East & Africa allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 319. Middle East & Africa allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 320. Middle East & Africa allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 321. Middle East & Africa allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 322. Middle East & Africa allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 323. Middle East & Africa allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 324. South Africa allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 325. South Africa allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 326. South Africa allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 327. South Africa allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 328. South Africa allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 329. South Africa allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 330. South Africa allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 331. South Africa allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 332. South Africa allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 333. South Africa allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 334. South Africa allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 335. South Africa allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 336. Saudi Arabia allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 337. Saudi Arabia allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 338. Saudi Arabia allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 339. Saudi Arabia allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 340. Saudi Arabia allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 341. Saudi Arabia allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 342. Saudi Arabia allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 343. Saudi Arabia allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 344. Saudi Arabia allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 345. Saudi Arabia allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 346. Saudi Arabia allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 347. Saudi Arabia allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 348. Rest of Middle East & Africa allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 349. Rest of Middle East & Africa allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 350. Rest of Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 351. Rest of Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 352. Rest of Middle East & Africa allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 353. Rest of Middle East & Africa allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 354. Rest of Middle East & Africa allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 355. Rest of Middle East & Africa allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 356. Rest of Middle East & Africa allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 357. Rest of Middle East & Africa allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 358. Rest of Middle East & Africa allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 359. Rest of Middle East & Africa allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Top-down approach
  • FIG. 3 Market estimation and forecast
  • FIG. 4 Market forecasting methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Allergy therapeutics industry, 360 degree synopsis, 2018 - 2032
  • FIG. 7 Industry landscape, 2018-2032 (USD Million)
  • FIG. 8 Growth potential analysis, by treatment type
  • FIG. 9 Growth potential analysis, by type
  • FIG. 10 Growth potential analysis, by route of administration
  • FIG. 11 Growth potential analysis, by distribution channel
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Company matrix analysis, 2022
  • FIG. 15 Strategy dashboard, 2022
目次
Product Code: 6560

The global allergy therapeutics market will showcase a 6.6% CAGR from 2023 to 2032. The increasing prevalence of allergies, including respiratory allergies like hay fever and food allergies, drives demand for effective treatments. Advancements in allergy diagnostics and immunotherapy techniques have improved treatment outcomes, driving business growth.

A growing awareness of allergies and their impact on health prompts individuals to seek medical intervention will bode well for the market expansion. Moreover, environmental factors like pollution and changing climate patterns lead to a higher incidence of allergies, opening a new scope for business growth.

Additionally, supportive healthcare policies, collaborative initiatives and the development of novel allergy therapeutics will further drive the market progress. Sanofi SA announced in July 2023 that it had agreed to acquire Qunol, a prominent U.S.-based brand specializing in the health and wellness industry.

The market is segregated based on treatment type, type, route of administration, distribution channel, and region.

Based on treatment type, the immunotherapy treatment segment will exhibit a 7% CAGR through 2032, driven by the increasing recognition of immunotherapy's effectiveness in addressing the root causes of allergies, reducing symptom severity, and providing long-term relief to patients, thus driving business growth for this treatment modality.

Based on type, the asthma segment will record 7.2% CAGR during 2023-2032, driven by factors such as increasing prevalence of asthma, expanding research in asthma therapeutics, and the development of advanced and more targeted treatments for asthma patients, fueling growth in the segment.

The intranasal route of administration segment will depict a 6.8% CAGR throughout the analysis period. The convenience and patient preference for non-invasive treatments, the effectiveness of intranasal delivery in managing allergic symptoms, and continuous innovation in intranasal allergy therapies will drive growth in the segment.

Regionally, the Asia Pacific allergy therapeutics industry is estimated to grow at a 7% CAGR during the analysis timeline, driven by the region's increasing prevalence of allergies and rising healthcare infrastructure. Moreover, the expanding patient awareness and growing demand for effective allergy treatments will foster business growth in the region.

Table of Contents

Chapter 1 Delivery Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Allergy therapeutics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Treatment type trends
    • 2.1.4 Type trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Distribution channel trends

Chapter 3 Allergy Therapeutics Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of allergic conditions
      • 3.2.1.2 Increased awareness about allergies and their impact on health
      • 3.2.1.3 Rising advancements in biotechnology, genomics, and personalized medicine
      • 3.2.1.4 Increasing demand for new and improved treatment options
      • 3.2.1.5 Increasing healthcare expenditure
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Adverse effects and safety concerns
      • 3.2.2.2 Lack of standardization in allergen extracts
      • 3.2.2.3 Undiagnosed or underdiagnosed cases due to a lack of awareness, mild symptoms, or limited access to healthcare
  • 3.3 Growth potential analysis
    • 3.3.1 By treatment type
    • 3.3.2 By type
    • 3.3.3 By route of adminstration
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Competitive analysis of major market players, 2022
  • 4.5 Competitive positioning matrix, 2022
  • 4.6 Strategic outlook matrix, 2022

Chapter 5 Allergy Therapeutics Market Size and Forecast, By Treatment type (USD Million)

  • 5.1 Key trends, by treatment type
  • 5.2 Anti-allergy drugs
    • 5.2.1 Antihistamines
    • 5.2.2 Corticosteroids
    • 5.2.3 Decongestants
    • 5.2.4 Other drugs
  • 5.3 Immunotherapy
    • 5.3.1 Sub-cutaneous immunotherapy (SCIT)
    • 5.3.2 Sub-lingual immunotherapy (SLIT)

Chapter 6 Allergy Therapeutics Market Size and Forecast, By Type (USD Million)

  • 6.1 Key trends, by type
  • 6.2 Eye allergy
  • 6.3 Asthma
  • 6.4 Skin allergy
  • 6.5 Food allergies
  • 6.6 Rhinitis
  • 6.7 Other allergy types

Chapter 7 Allergy Therapeutics Market Size and Forecast, By Route of administration (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Inhalers
  • 7.4 Intranasal
  • 7.5 Other routes of administration

Chapter 8 Allergy Therapeutics Market Size and Forecast, By Distribution Channel (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacies
  • 8.3 Retail pharmacies
  • 8.4 Other distribution channels

Chapter 9 Allergy Therapeutics Market Size and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Allergopharma
  • 10.2 Danaher
  • 10.3 AbbVie, Inc.
  • 10.4 Allergy Therapeutics plc
  • 10.5 Sanofi SA
  • 10.6 Pfizer, Inc.
  • 10.7 Teva Pharmaceutical Industries Ltd.
  • 10.8 GlaxoSmithKline plc
  • 10.9 F. Hoffmann-La Roche Ltd.
  • 10.10 Merck & Co., Inc.